平安(02318.HK)推出「AskBob医生」消化道肿瘤AI辅助决策系统
中国平安(02318.HK)宣布,推出「AskBob医生」消化道肿瘤AI辅助决策系统,为医生提供人工智能决策支持、药物调查、文献调查和翻译、在线论坛、网络课程等服务,系统对85种常见病的诊断精度达到90%,总体覆盖疾病超过1.5万种,已覆盖中国30个省级行政区约2万家医疗机构,服务超过45万名医生。
该系统由平安与新加坡国立大学医院,以及新加坡国立大学癌症中心联合开发,通过读取全球临床指南等高质量文献、综合分析和随机对照试验,可根据患者的疾病分期和患体状况,基於对最新的临床证据,为医生提供最佳的治疗推荐。
平安表示,该系统与多学科肿瘤学委员会的诊断一致率达到96%,新加坡国立大学医院正准备在全球招募1,000名患者协助该系统获得多中心临床认证。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.